Home › Cancer (all types) › NCT06338475
A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer
Who can join
Ages 18 to 39 · Men
Full eligibility criteria
Inclusion Criteria: * Age 18 to 39 years at time of consent * Male gender; self-identified * A confirmed diagnosis of cancer (any stage) * Diagnosed with cancer between the ages of 15 and 39 * Hispanic/Latino identification * A score ≤ 1.8 on the Goal Navigation Scale or ≥ 4 on the Distress Thermometer * English or Spanish fluency Exclusion Criteria: * lifetime history of bipolar disorder, schizophrenia, schizoaffective disorder (self-report) * compromised cognitive capacity * self-reported medical condition or medication use known to confound measures of systemic inflammation (e.g., autoimmune disorder, active infection)
About the study
Building upon the results of a single-arm trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET), this trial is a randomized-controlled biobehavioral pilot trial of GET versus a time-and attention matched control (Instrumental Supportive Listening; ISL) in Latino/Hispanic young adult survivors of adolescent and young adult (AYA) cancer (age 15-39 years at diagnosis). Outcomes include improved distress symptoms, emotion regulation, goal navigation skills, and changes in stress-sensitive biomarkers.
Participants will be randomized to receive six sessions of GET or ISL delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary and secondary psychological outcomes prior to (T0), immediately after (T1), and twelve weeks after intervention (T2). Additionally, identified biomarkers will be measured at baseline and at T1, and T2.
What is being tested
- Goal-Focused Emotion-Regulation Therapy (GET) (behavioral)
- Individual Supportive Listening (ISL) (behavioral)
Sponsor: University of California, Irvine · Participants: 100 · Started: Jun 1, 2024
Contact the study team
- Michael A Hoyt, PhD · Phone: 949-824-5281
Official record on ClinicalTrials.gov — NCT06338475
Locations in the U.S.
| California | University of California, Irvine, Irvine |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.